atorvastatin has been researched along with oxyntomodulin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, TW; Derving Karsbøl, J; Golor, G; Hausner, H; Holst, AG; Jacobsen, JB; Wagner, FD | 1 |
| Cui, X; de la Peña, A; Geiser, J; Loghin, C | 1 |
| Alberts, JJ; Dickinson, GL; Hall, SD; Hillgren, KM; Kolur, A; Loghin, C; Morse, BL; Posada, MM; Rehmel, J; Tham, LS | 1 |
| Kristensen, K; Langeskov, EK | 1 |
2 trial(s) available for atorvastatin and oxyntomodulin
| Article | Year |
|---|---|
Effect of Semaglutide on the Pharmacokinetics of Metformin, Warfarin, Atorvastatin and Digoxin in Healthy Subjects.
Topics: Adolescent; Adult; Atorvastatin; Cross-Over Studies; Digoxin; Drug Interactions; Drug Therapy, Combination; Female; Glucagon-Like Peptides; Healthy Volunteers; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Warfarin; Young Adult | 2017 |
No Dose Adjustment is Recommended for Digoxin, Warfarin, Atorvastatin or a Combination Oral Contraceptive When Coadministered with Dulaglutide.
Topics: Administration, Oral; Adolescent; Adult; Aged; Atorvastatin; Contraceptives, Oral; Digoxin; Drug Interactions; Female; Glucagon-Like Peptides; Healthy Volunteers; Humans; Hypoglycemic Agents; Immunoglobulin Fc Fragments; Injections, Subcutaneous; Male; Middle Aged; Recombinant Fusion Proteins; Warfarin; Young Adult | 2017 |
2 other study(ies) available for atorvastatin and oxyntomodulin
| Article | Year |
|---|---|
Physiologically-Based Pharmacokinetic Modeling of Atorvastatin Incorporating Delayed Gastric Emptying and Acid-to-Lactone Conversion.
Topics: Atorvastatin; Cells, Cultured; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Interactions; Gastric Acid; Gastroparesis; Glucagon-Like Peptides; Hepatocytes; Humans; Immunoglobulin Fc Fragments; Lactones; Models, Biological; Organic Anion Transporters; Recombinant Fusion Proteins | 2019 |
Population pharmacokinetic of paracetamol and atorvastatin with co-administration of semaglutide.
Topics: Acetaminophen; Atorvastatin; Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Hypoglycemic Agents | 2022 |